Literature DB >> 3746632

Effect of albumin on hepatic uptake of warfarin in normal and analbuminemic mutant rats: analysis by multiple indicator dilution method.

S C Tsao, Y Sugiyama, Y Sawada, S Nagase, T Iga, M Hanano.   

Abstract

Multiple indicator dilution studies of warfarin uptake were carried out on isolated perfused rat livers in the presence and absence of bovine serum albumin (BSA) in the perfusate using normal rats and Nagase analbuminemic rats (NAR). A distributed model was fitted to the dilution data and estimates of influx, efflux, and sequestration rate constants were obtained. In both groups of rats, the intrinsic clearance for unidirectional hepatic uptake (CLint,influx) of warfarin in the presence of 1.6 g/dl BSA was approximately 37-45% of that in the absence of BSA, while the unbound fraction of warfarin with 1.6 g/dl BSA in the perfusate was only 4.2% of that in the absence of BSA. Thus the degree of BSA-induced reduction of the value of CLint,influx and that of the unbound fraction are different. From these observations, it was found that the hepatic uptake of warfarin is not driven solely by the unbound concentration of warfarin, supporting the recent concepts of albumin-mediated transport for tightly albumin bound ligands as reported by Ockner et al. In addition, the fact that the same hepatic uptake mechanism of warfarin was also observed in NAR suggested that the hepatic uptake of warfarin may not necessarily require a special albumin receptor on the hepatocyte surface.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3746632     DOI: 10.1007/bf01059283

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  20 in total

1.  INITIAL DISTRIBUTION AND RATE OF UPTAKE OF SULFOBROMOPHTHALEIN IN THE LIVER.

Authors:  C A GORESKY
Journal:  Am J Physiol       Date:  1964-07

2.  Comparative pharmacokinetics of coumarin anticoagulants. X. Relationship between distribution, elimination, and anticoagulant action of warfarin.

Authors:  A Yacobi; L B Wingard; G Levy
Journal:  J Pharm Sci       Date:  1974-06       Impact factor: 3.534

3.  The assay of warfarin in plasma or stool.

Authors:  R J Lewis; L P Ilnicki; M Carlstrom
Journal:  Biochem Med       Date:  1970-12

4.  Analysis of multiple indicator dilution curves for estimation of renal tubular transport parameters.

Authors:  Y Sawada; N Itoh; Y Sugiyama; T Iga; M Hanano
Journal:  Comput Methods Programs Biomed       Date:  1985-05       Impact factor: 5.428

5.  Receptor for albumin on the liver cell surface may mediate uptake of fatty acids and other albumin-bound substances.

Authors:  R Weisiger; J Gollan; R Ockner
Journal:  Science       Date:  1981-03-06       Impact factor: 47.728

6.  Uptake of materials by the intact liver. The exchange of glucose across the cell membranes.

Authors:  C A Goresky; B E Nadeau
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

7.  Albumin-deficient rat mutant.

Authors:  S Nagase; K Shimamune; S Shumiya
Journal:  Science       Date:  1979-08-10       Impact factor: 47.728

8.  On the uptake of materials by the intact liver. The transport and net removal of galactose.

Authors:  C A Goresky; G G Bach; B E Nadeau
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

9.  Albumin-mediated transport of rose bengal by perfused rat liver. Kinetics of the reaction at the cell surface.

Authors:  E L Forker; B A Luxon
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

10.  Albumin helps mediate removal of taurocholate by rat liver.

Authors:  E L Forker; B A Luxon
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

View more
  13 in total

1.  Analysis of nonlinear and nonsteady state hepatic extraction with the dispersion model using the finite difference method.

Authors:  A Hisaka; Y Sugiyama
Journal:  J Pharmacokinet Biopharm       Date:  1998-10

2.  Analysis of nonlinear hepatic clearance of a cyclopentapeptide, BQ-123, with the multiple indicator dilution method using the dispersion model.

Authors:  A Hisaka; T Nakamura; Y Sugiyama
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

3.  Dynamic determination of kinetic parameters for the interaction between polypeptide hormones and cell-surface receptors in the perfused rat liver by the multiple-indicator dilution method.

Authors:  H Sato; Y Sugiyama; Y Sawada; T Iga; S Sakamoto; T Fuwa; M Hanano
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

Review 4.  Receptor-mediated transport of peptide hormones and its importance in the overall hormone disposition in the body.

Authors:  Y Sugiyama; M Hanano
Journal:  Pharm Res       Date:  1989-03       Impact factor: 4.200

5.  Lack of linear correlation between hepatic ligand uptake rate and unbound ligand concentration does not necessarily imply receptor-mediated uptake.

Authors:  R H Smallwood; D J Morgan; G W Mihaly; R A Smallwood
Journal:  J Pharmacokinet Biopharm       Date:  1988-08

6.  Kinetic analysis of albumin-mediated uptake of warfarin by perfused rat liver.

Authors:  S C Tsao; Y Sugiyama; Y Sawada; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1988-04

7.  Evaluation of the uptake of pravastatin by perfused rat liver and primary cultured rat hepatocytes.

Authors:  M Ishigami; T Tokui; T Komai; K Tsukahara; M Yamazaki; Y Sugiyama
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

Review 8.  Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics.

Authors:  M Yamazaki; H Suzuki; Y Sugiyama
Journal:  Pharm Res       Date:  1996-04       Impact factor: 4.200

9.  Comparison of the blood-brain barrier and liver penetration of acridine antitumor drugs.

Authors:  E M Cornford; D Young; J W Paxton
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

10.  Kinetics of hepatic transport of 4-methylumbelliferone in rats. Analysis by multiple indicator dilution method.

Authors:  S Miyauchi; Y Sugiyama; Y Sawada; K Morita; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1987-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.